# BioReason v0.2 Knowledge Expansion Strategy

**Document Version**: `1.0.0`  
**Execution Timestamp**: `2026-09-16T00:26:45Z`  
**Status**: `STRATEGIC_PLANNING_DOCUMENT`  

---

## 1. Context & Motivation

During Phase 3 Increments 4–6, the **BioReason v0.2** reasoning platform established high structural causal reasoning (+13.0 pp gain on `BioReasonBench-v0.2`, 95.0% accuracy, 0.00% false alarms). However, the residual error audit revealed 11 remaining failure modes rooted in **factual biological and assay-specific knowledge gaps** (e.g. LC-MS electrospray polarity-matched internal standard suppression rules, phylogenetic covarion/heterotachy substitution models).

This document evaluates five strategic architectural pathways to expand domain knowledge in future versions (BioReason v0.3+) without corrupting the core causal reasoning engine.

---

## 2. Comparative Evaluation of Architectural Pathways

```
┌────────────────────────────────────────────────────────────────────────────────────────────────────────┐
│                              KNOWLEDGE EXPANSION PATHWAY COMPARISON                                    │
├──────────────────────────┬──────────────────┬─────────────────┬──────────────────┬─────────────────────┤
│ Strategy Pathway         │ Scientific Power │ Reasoning Risk  │ Compute Cost     │ Best Use Case       │
├──────────────────────────┼──────────────────┼─────────────────┼──────────────────┼─────────────────────┤
│ A. Continued Pretraining │ High             │ High (Forgetting│ Very High (GPUs) │ Foundational terms  │
│ B. Structured RAG        │ High             │ Low             │ Low (Latency)    │ Instrument manuals  │
│ C. Domain-Specific SFT   │ Very High        │ Low (with replay│ Medium           │ Complex assay rules │
│ D. Tool-Aware Execution  │ Very High        │ Low             │ Medium           │ Live data auditing  │
│ E. No Action (Boundary)  │ Low              │ Zero            │ Zero             │ Pure logic baseline │
└──────────────────────────┴──────────────────┴─────────────────┴──────────────────┴─────────────────────┘
```

### Pathway A: Continued Pretraining (CPT)
- **Mechanism**: Unsupervised causal language modeling on 10B+ tokens of PubMed Central full-texts, bioRxiv preprints, and instrument application notes.
- **Trade-offs**: Broad factual exposure; high risk of catastrophic forgetting of calibration and specificity; requires massive compute.

### Pathway B: Structured Knowledge Retrieval (RAG)
- **Mechanism**: Dynamic vector retrieval against structured assay knowledge bases (e.g. 10x Genomics manuals, Illumina whitepapers, Metabolomics Standards Initiative guidelines).
- **Trade-offs**: Zero risk of model forgetting; highly auditable; introduces context window overhead and latency.

### Pathway C: Domain-Specific Failure-Driven SFT (Recommended Primary)
- **Mechanism**: Expanding the failure-driven SFT curriculum with curated episodes specifically pairing factual assay mechanics with ExperimentGraph invariants.
- **Trade-offs**: Directly integrates factual knowledge with causal critique; proven anti-forgetting stability via 25% experience replay.

### Pathway D: Tool-Aware Bioinformatic Execution
- **Mechanism**: Integrating executable verification sandboxes (e.g. `fastqc`, `samtools`, `DESeq2`, `Scanpy`) via structured function calling.
- **Trade-offs**: Solves complex empirical calculation gaps; requires rigorous container security.

---

## 3. Recommended Phased Roadmap (BioReason v0.3 Foundation)

1. **Phase 1 (v0.3 Foundations)**: Implement **Pathway C (Domain-Specific SFT Expansion)** to resolve the 11 cataloged backlog items in [`V0_2_KNOWLEDGE_GAP_BACKLOG.md`](file:///Users/albertopaz/Biomindv2/V0_2_KNOWLEDGE_GAP_BACKLOG.md).
2. **Phase 2 (Enterprise Tool Integration)**: Implement **Pathway B (Structured RAG)** for dynamic instrument parameter injection in production analysis pipelines.
